Risk analysis of the re-emergence of Plasmodium vivax malaria in Japan using a stochastic transmission model

Environmental Health and Preventive Medicine

Volumn 16, Issue 3, 2011, Pages 171-177

  Bitoh, Tomoyuki ^a   Fueda, Kaoru ^a   Ohmae, Hiroshi ^b   Watanabe, Mamoru ^b   Ishikawa, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Anopheles sinensis; Plasmodium vivax; Re emergence; Stochastic simulation; Toyama

Indexed keywords

ANOPHELES; ANOPHELES SINENSIS; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; IMMIGRANT; INFECTION RISK; JAPAN; NONHUMAN; PLASMODIUM VIVAX MALARIA; RELAPSE; RESIDENTIAL AREA; RISK ASSESSMENT; SEASONAL VARIATION; STOCHASTIC MODEL; ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; DISEASE CARRIER; HUMAN; MIGRATION; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM VIVAX; SEASON; STATISTICS;

ANOPHELES SINENSIS; PLASMODIUM VIVAX;

ANIMALS; ANOPHELES; COMPUTER SIMULATION; EMIGRANTS AND IMMIGRANTS; HUMANS; INSECT VECTORS; JAPAN; MALARIA, VIVAX; MODELS, BIOLOGICAL; PLASMODIUM VIVAX; RISK ASSESSMENT; SEASONS; STOCHASTIC PROCESSES;

EID: 79961181523     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-010-0184-8     Document Type: Article

References (35)

1. Otsuru M. Malaria studies in Japan after World War II. Part I. Epidemiological aspects of postwar malaria. Jpn J Exp Med. 1959;30:23-32.
2. Tanaka S, Sugita S, Marui E. Two types of malaria epidemics during the postwar occupation period in Japan. Nippon Eiseigaku Zasshi 2009;64:3-13 (article in Japanese with English abstract).
3. National Institute of Infectious Diseases. Infectious Disease Surveillance Center. Malaria, 1999-2005. Infect Agents Surveill Rep. 2007;28:1-3 (in Japanese). http://idsc.nih.go.jp/iasr/28/323/tpc323-j.html.
4. Toyama Institute of Health. Japanese encephalitis epidemic predicted surveillance for thirty-five years in Toyama. In: Nagai Y, Watanabe M, editors. Toyama: Toyama Institute of Public Health; 2004 (article in Japanese).
5. Public Health and Science Center in Shiga. Surveillance of West Nile virus vector mosquito, 2008 (in Japanese). http://www.pref.shiga.jp/e/ef45/ kansen-c/file/2008-WNV.pdf.
6. Lee YC, Tang CS, Ang LW, Han HK, James L, Goh KT. Epidemiological characteristics of imported and locally-acquired malaria in Singapore. Ann Acad Med Singap. 2009;8:40-9.
7. Hanna JN, Ritchie SA, Eisen DP, Cooper RD, Brookes DL, Montgomery BL. An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. Med J Aust. 2004;180:24-8. (Pubitemid 38049310)
8. Armengaud A, Legros F, D'Ortenzio E, Quatresous I, Barre H, Houze S, et al. A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Travel Med Infect Dis. 2008;6: 36-40. (Pubitemid 351384296)
9. Sunstrum J, Elliott LJ, Barat LM, Walker ED, Zucker JR. Probable autochthonous Plasmodium vivax malaria transmission in Michigan: case report and epidemiological investigation. Am J Trop Med Hyg. 2001;65:949-53. (Pubitemid 34049502)
10. Rogers DJ, Randolph SE. The global spread of malaria in a future, warmer world. Science. 2000;289:1763-6.
11. Paik YH, Ree HI, Shim JC. Malaria in Korea. Kyung Hee Univ Med J. 1987;12:17-31.
12. Chai JY. Re-emerging Plasmodium vivax malaria in the Republic of Korea. Korean J Parasitol. 1999;37:129-43.
13. Yeom J, Ryu SH, Oh S, Lee WJ, Kim TS, Kim KH, et al. Status of Plasmodium vivax malaria in the Republic of Korea during 2001-2003. Am J Trop Med Hyg. 2005;73:604-8. (Pubitemid 41324269)
14. Kho WG, Jang JY, Hong ST, Lee HW, Lee WJ, Lee JS. Border malaria characters of reemerging vivax malaria in the Republic of Korea. Korean J Parasitol. 1999;37:71-6.
15. De Zoysa AP, Mendis C, Gamage-Mendis AC, Weerasinghe S, Herath PRJ, Mendis KN. A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission- blocking immunity in an endemic area. Bull World Health Organ. 1991;69:725-34.
16. Ishikawa H, Ishii A, Nagai N, Ohmae H, Harada M, Suguri S, et al. A mathematical model for the transmission of Plasmodium vivax malaria. Parasitol Int. 2003;52:81-93. (Pubitemid 36110524)
17. Dietz K, Molineaux L, Thomas A. A malaria model tested in the African savannah. Bull World Health Organ. 1974;50:347-57.
18. Fujita K, Chen TT, Nishina T, Ishikawa H. Modeling of reemerging Plasmodium vivax in the north area of the Republic of Korea based on a mathematical model. J Fac Environ Sci Technol Okayama Univ. 2006;11:1-7.
19. Ponçon N, Tran A, Toty C, Luty AJ, Fontenille D. A quantitative risk assessment approach for mosquito-borne diseases: malaria re-emergence in southern France. Malar J. 2008;7:147.
20. Nakagawa Y, Ueki M, Fueda K, Ohmae H, Ishikawa H. Risk assessment of re-emerging Plasmodium falciparum on Ishigaki Island using a stochastic transmission model. Trop Med Health. 2009;37:97-107.
21. Ministry of Internal Affairs and Communications Bureau of Statistics of Japan. National census, 2005 (in Japanese). http://www.city.himi.toyama.jp/ct/ other000004400/0120-100406-913.pdf.
22. Ree HI. Studies on Anopheles sinensis, the vector species of vivax malaria in Korea. Korean J Parasitol. 2005;43:75-92.
23. World Health Organization. Manual on practical entomology in malaria. Part II. Geneva, WHO; 1995. WHO Offset Publication No. 13.
24. Lee KJ, Kim CB, Choi BJ, Park KH, Park JK. Analysis of vivax malaria cases in Gangwon-do (Province), Korea in the year 2000. Korean J Parasitol. 2001;39:301-6.
25. Bray RS, Garnham PCC. The life-cycle of primate malaria parasites. Br Med Bull. 1982;38:117-22. (Pubitemid 12008179)
26. Oh MD, Shin H, Shin D, Kim U, Lee S, Kim N, et al. Clinical features of vivax malaria. Am J Trop Med Hyg. 2001;65:143-6. (Pubitemid 32744220)
27. Jeffery GM, Young MD, Eyles DE. The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine-and pyrimethamine-treated cases. Am J Hyg. 1956;64:1-11.
28. Nacher M, Silachamroon U, Singhasivanon P, Wilairatana P, Phumratanaprapin W, Fontanet A, et al. Risk factors for Plasmodium vivax gametocyte carriage in Thailand. Am J Trop Med Hyg. 2004;71:693-5. (Pubitemid 40075615)
29. Lee JS, Kho WG, Lee HW, Seo M, Lee WJ. Current status of vivax malaria among civilians in Korea. Korean J Parasitol. 1998;36:241-8.
30. Lee HI, Lee JS, Shin EH, Lee WJ, Kim YY, Lee KR. Malaria transmission potential by Anopheles sinensis in the Republic of Korea. Korean J Parasitol. 2001;39:185-92.
31. Kiszewski A, Mellinger A, Spielman A, Malaney P, Sachs SE, Sachs J. A global index representing the stability of malaria transmission. Am J Trop Med Hyg. 2004;70:486-98. (Pubitemid 38658142)
32. Park CG, Chwae YJ, Kim JI, Lee JH, Hur GM, Jeon BH, et al. Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg. 2000;62:720-5. (Pubitemid 32281494)
33. Tada MS, Marques RP, Mesquita E, Dalla Martha RC, Rodrigues JA, Costa JD, et al. Urban malaria in the Brazilian Western Amazon Region I: high prevalence of asymptomatic carriers in an urban riverside district is associated with a high level of clinical malaria. Mem Inst Oswaldo Cruz. 2007;102:263-9. (Pubitemid 46869322)
34. Eliades MJ, Shah S, Nguyen-Dinh P, Newman RD, Barber AM, Roberts JM, et al. Malaria Surveillance United States, 2003. Centers for Disease Control and Prevention. Morb Mortal Wkly Rep. 2005;54(SS02):25-39.
35. Tang JS, Chen CL, Ko WC, Chuang CC. Imported malaria in southern Taiwan from 1991 to 2002: a single hospital's experience. Kaohsiung J Med Sci. 2003;19:398-404.